The Economic Crisis and Cancer Chemotherapy: The Role of the Oncologist

Smith T.J. , Hillner B.E. : Bending the cost curve in cancer care. N Engl J Med, 364: 2060–2065, 2011.

Stark C.J. : The economic burden of cancer in Europe. EJHP Practice, 12: 53–56, 2006.

Bernardi A. , Jirillo A. , Pegoraro R. , Bonavina G. : Allocation of public sources in oncology: which role can ethics play? Ann Oncol, 18: 1129–1131, 2007.

de Belvis A.G. , Ferrè F. , Specchia M.L. , Valerio L. , Fattore G. , Ricciardi W. : The financial crisis in Italy: implications for the healthcare sector. Health Policy, 106: 10–16, 2012.

Garattini S. , Bertelè V. : Ethics in clinical research. J Hepatol, 51: 792–797, 2009.

Apolone G. , Tafuri G. , Trotta F. , Garattini S. : A new anti-cancer drug in the market: Good news for investors or for patients? Eur J Cancer, 44: 1786–1788, 2008.

Hodi F.S. , O'Day S.J. , McDermott D.F. , Weber R.W. , Sosman J.A. , Haanen J.B. , Gonzalez R. , Robert C. , Schadendorf D. , Hassel J.C. , Akerley W. , van den Eertwegh A.J. , Lutzky J. , Lorigan P. , Vaubel J.M. , Linette G.P. , Hogg D. , Ottensmeier C.H. , Lebbé C. , Peschel C. , Quirt I. , Clark J.I. , Wolchok J.D. , Weber J.S. , Tian J. , Yellin M.J. , Nichol G.M. , Hoos A. , Urba W.J. : Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med, 363: 711–723, 2010.

Jirillo A. , Imbevaro S. , Mazurek M. : The impact of new cancer drugs in real practice oncology: a monoinstitutional experience. Immunopharmacol Immunotoxicol, Jan 13, 2012 [Epub ahead of print].

Sobrero A. , Bruzzi P. : Incremental advance or seismic shift? The need to raise the bar of efficacy for drug approval. J Clin Oncol, 27: 5868–5873, 2009.